Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)
about
Biochemical characterization of human collagenase-3The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interactionCloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilageThe X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificityThe metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidasesCollaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gelsRole of matrix metalloproteinases in dental caries, pulp and periapical inflammation: An overviewMatrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2: BINDING STUDIES AND CRYSTAL STRUCTUREHydrolysis of triple-helical collagen peptide models by matrix metalloproteinasesMatrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic propertiesEsculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin MInsulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alphaMatrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosisTIMP-2 is required for efficient activation of proMMP-2 in vivoActivation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and IIPlasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint.Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress.The extracellular matrix contributes to mechanotransduction in uterine fibroidsHeparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells.Mouse matrix metalloprotease-1a (Mmp1a) gives new insight into MMP functionThe role of matrix metalloproteinases in vascular disease.Tumor necrosis factor-α-accelerated degradation of type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivoMatrix metalloproteinase-3 in odontoblastic cells derived from ips cells: unique proliferation response as odontoblastic cells derived from ES cellsIdentification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3).The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases.The role of plasminogen activators in the regulation of connective tissue metalloproteinases.Plasminogen activator inhibitor-1 in the pathogenesis of asthma.The interface between catalytic and hemopexin domains in matrix metalloproteinase-1 conceals a collagen binding exosite.Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion developmentMatrix metalloproteinase-9 regulates survival of neurons in newborn hippocampusMatrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.Current concepts of the biology of tooth eruption.Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular diseaseExpression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritisThe proteasome: a macromolecular assembly designed to confine proteolysis to a nanocompartment.Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain.
P2860
Q24318765-29A1A226-1BD0-4480-AD84-A47E0D02146DQ24336413-CD3320C9-5B35-4F46-A5A7-0A142EE349AFQ24562729-666DD084-8277-45E5-9B94-A00033C7298DQ24596245-828CC9B5-A692-4602-97A5-BC75B2B2D380Q24675153-84EAE128-FFB4-4CC6-8D87-B376C4D23E41Q24806806-34EE74E0-0947-4276-9E44-D7AFE5588C99Q26775659-AB045A4E-996B-46B6-AF90-041A64741D86Q27678085-F078DF14-7732-4175-9A2A-C965C8F8CA77Q28143236-39381928-5F7E-4C7F-B3AB-8BC70E694293Q28268723-8B00339C-0F24-4C5A-A344-5FEE5E685E51Q28345787-076D731E-6201-4710-8FA9-06925DBEA96EQ28348472-9618D7A7-C4D2-4513-8177-B89F415C32A6Q28386047-F7987507-EC95-4768-B0B5-C5334951F3D8Q28512714-B1A508B9-8A84-4A95-9C10-B44339CB2048Q28618827-2806A558-4C21-49B3-AF1A-35324931E125Q33287995-FEF6B68C-3441-4509-BD97-3337BFCA2D6CQ33576701-47214F0A-1F58-4241-BDC1-0BB837724FAEQ33883174-72FE0570-AB9E-4E39-A7E6-D42CFF3369AEQ33930628-2ED3C518-1AFC-45EB-AA6F-288C64A00858Q34143433-C538BE81-BC72-42A6-AD50-68C67FE0519AQ34193277-41414AB3-D64C-4B14-A3A2-50F7EFB7A6BEQ34488791-00EE3E9C-7366-497C-A499-E806C6100252Q34981650-A368D4E9-EFCC-40EE-9934-EE96F75DF541Q34990215-483D9945-AA5E-4D81-9F58-FEABA0922BDBQ35073126-6C444338-2749-4FA3-A7EA-9674FA9DF73CQ35075746-3C7F842D-7B26-4FE4-BEE8-606ADF57258FQ35123653-6C8A77DD-9FFE-4CBD-ADA5-720E73348242Q35240608-F69CECBA-1BD3-4E40-AD83-B64982970737Q35634264-12539358-4A0E-4505-96BE-E5293EF68979Q35639806-6AF12A3B-D397-463C-B9E3-E56201D23B36Q35753125-628AD631-5309-4E9C-A10B-7AC98AE0CC22Q35874475-B080D1B7-0E9D-42D1-95AB-28CF8A40C52FQ36009930-5DEFA7B2-6C68-4A83-BD9B-4496FDE22E66Q36043876-76EFEE18-1091-49BE-8658-4D315D371AE0Q36477722-74ED7C59-EFE9-48F6-882F-7619E34E47BFQ36620240-160AA7CF-AF2A-4E1E-8EEB-F136351F3603Q36644577-A9D581D1-7276-4EC0-9F24-1842C1267425Q36784433-F3B8D703-A418-415A-AFFE-24D59C0CA341Q36862775-8C9E38BF-003B-4CEF-81A7-6F63F88B9311Q36885449-7B428AA4-DFDC-4B41-A687-9A7610EF5FFE
P2860
Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)
description
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1990
@ast
im November 1990 veröffentlicher wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1990/11/06)
@sk
vědecký článek publikovaný v roce 1990
@cs
wetenschappelijk artikel (gepubliceerd op 1990/11/06)
@nl
наукова стаття, опублікована в листопаді 1990
@uk
مقالة علمية (نشرت في 6-11-1990)
@ar
name
Mechanisms of activation of ti ...... alloproteinase 3 (stromelysin)
@ast
Mechanisms of activation of ti ...... alloproteinase 3 (stromelysin)
@en
Mechanisms of activation of ti ...... alloproteinase 3 (stromelysin)
@nl
type
label
Mechanisms of activation of ti ...... alloproteinase 3 (stromelysin)
@ast
Mechanisms of activation of ti ...... alloproteinase 3 (stromelysin)
@en
Mechanisms of activation of ti ...... alloproteinase 3 (stromelysin)
@nl
prefLabel
Mechanisms of activation of ti ...... alloproteinase 3 (stromelysin)
@ast
Mechanisms of activation of ti ...... alloproteinase 3 (stromelysin)
@en
Mechanisms of activation of ti ...... alloproteinase 3 (stromelysin)
@nl
P2093
P356
P1433
P1476
Mechanisms of activation of ti ...... alloproteinase 3 (stromelysin)
@en
P2093
P304
10261-10270
P356
10.1021/BI00496A016
P407
P577
1990-11-01T00:00:00Z